Type	Name	Date
Indenture	Indenture, by and between Orexigen Therapeutics, Inc. and U.S. Bank National Association, as trustee	02/24/2017
Indenture	Supplemental Indenture, among Orexigen Therapeutics, Inc., U.S. Bank National Association, as trustee and collateral agent, and certain holders of 0% Convertible Senior Secured Notes due 2020	02/17/2017
Indenture	Supplemental Indenture, among Orexigen Therapeutics, Inc., U.S. Bank National Association, as trustee and collateral agent, and certain holders of 0% Convertible Senior Secured Notes due 2020	12/20/2016
Indenture	Indenture, by and between the Company and U.S. Bank National Association, as trustee and collateral agent, including the Form of 0% Convertible Senior Secured Note due 2020	03/25/2016
Securities purchase agreement	Securities Purchase Agreement, by and among the Company and each purchaser party thereto	03/15/2016

Type	Name	Date
Other	Security Agreement, by and among the Company, the guarantors party thereto from time to time, and U.S. Bank National Association, as collateral agent	03/25/2016